A 15 year institutional experience of well-differentiated follicular cell-derived thyroid carcinomas; impact of the new 2017 TNM and WHO Classifications of Tumors of Endocrine Organs on the epidemiological trends and pathological characteristics
- PMID: 31838728
- DOI: 10.1007/s12020-019-02158-7
A 15 year institutional experience of well-differentiated follicular cell-derived thyroid carcinomas; impact of the new 2017 TNM and WHO Classifications of Tumors of Endocrine Organs on the epidemiological trends and pathological characteristics
Abstract
Purpose: Our study aimed to describe the evolution of the rate of pathological subtypes of well-differentiated follicular-cell derived thyroid carcinomas (DTCs) in the Department of Pathology, Emergency County Hospital Targu-Mures, Romania over a 15 year period and to assess the impact the new 2017 WHO and TNM classifications of thyroid tumors had on our cases.
Methods: The pathological data were retrieved from the original pathological reports. After applying the exclusion criteria the remaining cases were reviewed on a double-headed microscope and reclassified according to the 2017 WHO and TNM staging system. The follow-up data were collected from the Institute of Oncology Cluj-Napoca, Romania.
Results: Our study included 396 cases of DTCs (375 papillary, 11 follicular, and 10 Hürthle cell carcinomas). PTCs revealed a significant increasing trend over the study period, whereas follicular and Hurthle cell carcinomas remain rare; 125/131 of noninvasive encapsulated follicular variant PTC (EFVPTC) were reclassified as noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTPs), resulting in a 33.3% reduction in the number of PTCs. According to 2017 TNM stage-grouping 31% of 271 patients with DTC were downstaged. Follow-up data were available for most of the patients (65.7%, mean period 58.1 months). All patients with noninvasive EFVPTC were disease free at the last clinical assessment.
Conclusions: The increasing rate of PTC was maintained even after exclusion of NIFTP. By applying 2017 TNM criteria, a significant number of DTC cases were downstaged into a more favorable group. Follow-up data highlight the indolent behavior of noninvasive EFVPTCs reclassified as NIFTPs.
Keywords: Downstaging; NIFTP; Papillary thyroid carcinoma; Prevalence; TNM-8; WHO 2017.
References
-
- B.W. Stewart, C. Wild, World Cancer Report, 3rd edn. (International Agency for Research on Cancer (IARC), Lyon, 2014)
-
- Y.E. Nikiforov, P.W. Biddinger, L.D.R. Thompson, Diagnostic Pathology and Molecular Genetics of the Thyroid (Lippincott, Williams and Wilkins, Philadelphia, USA, 2012)
-
- N. Berger, A. Borda, Pathologie thyroidienne, parathyroidienne et surrenalienne (Sauramps Medical, Montpellier, France, 2010)
-
- R.V. Lloyd, R.Y. Osamura, G. Kloppel, J. Rosai, WHO Classification of Tumours of Endocrine Organs (International Agency for Research on Cancer (IARC), Lyon, 2017)
MeSH terms
LinkOut - more resources
Full Text Sources
Medical